Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Faes Farma ( (ES:FAE) ) has provided an update.
Faes Farma has received approval from the European Union for a new manufacturing plant in Derio, Bizkaia, which is set to double its current production capacity. This expansion allows for the immediate commencement of commercialization of medicines across Spain, Europe, and eventually other markets, showcasing the company’s commitment to operational excellence and technological advancement.
More about Faes Farma
Faes Farma operates in the pharmaceutical industry, specializing in the manufacturing of medicines. The company is focused on expanding its production capabilities and market reach, particularly in Europe.
YTD Price Performance: 0.57%
Average Trading Volume: 4,411
Technical Sentiment Consensus Rating: Sell
Current Market Cap: €1.09B
For a thorough assessment of FAE stock, go to TipRanks’ Stock Analysis page.